One platform connecting startups, corporations, research institutions, regions and investors
Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE
1. Technology overview
EM2AI Pte Ltd describes itself as an emerging medical tech company headquartered in Singapore, at 2 Jurong East Street 21, with offices in Johor Bahru and Subang Jaya, Malaysia. The footer shows 2019-2026 but the founding year is not stated. A January 2025 announcement describes it as an associated company of Q&M Dental Group.
EM2AIScan performs AI radiograph detection on orthopantomogram, bitewing and periapical views, with automated dental charting, dental health reports and guided diagnosis. EM2Clinic adds multi-clinic management, patient records, appointments, charting, billing and analytics. The site claims 60,000+ x-rays analyzed, 150+ clinics and 300+ dentists.
2. Highlighted features & specifications
- AI radiograph detection: orthopantomogram, bitewing and periapical views.
- Automated charting: dental charts generated from AI findings.
- Dental health reports: patient-facing reports.
- Guided diagnosis: AI-supported clinical prompts.
- EM2Clinic: multi-clinic and patient management, appointments, EMR and billing.
- Analytics: business analytics with WhatsApp Business communication.
3. Potential application
Distributors in Vietnam can bring AI radiograph detection to dental clinics under the licence announced in January 2025. Dental chains can combine AI screening with multi-branch management. Dental schools can use charting reports for training.
4. Benefits
Automated charting and reports shorten radiograph review. Combined AI and clinic management reduces the number of separate tools. A regional footprint in Singapore and Malaysia supports local deployments. Licences in Vietnam, Thailand, the Philippines and Indonesia, announced January 2025, allow sale in those markets.
5. Market trends & opportunities
Southeast Asian dental groups are adding AI imaging and cloud management. Regulatory licences across several ASEAN markets let regional vendors expand through distributors, and Vietnam is among the markets covered.
6. Other information
EM2AI Pte Ltd, Singapore. Licences announced 13 January 2025: Thailand FDA Category 2, Philippines FDA Class B, Vietnam DMEC Class B and Indonesia Ministry of Health Class C. The company says it is seeking distributors. Data Protection Notice last updated 24 June 2024.
